Vir Biotechnology, Inc. at the Annual Meeting of Stockholders on May 19, 2023, elected Elliott Sigal as Class I Director, to serve until the Company's 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.9 USD | +0.34% |
|
-2.63% | -11.53% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.53% | 1.21B | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology, Inc. Elects Elliott Sigal as Director